Inside the Saibailan Pharmaceutical AI Conference: Weiming Penguin Co-founder & President Tian Ying Explains How to Deploy Enterprise AI Securely
Article images may contain Chinese text.




April 18, 2026, Beijing.
The 2nd Saibailan Pharmaceutical AI Applications Conference officially opened. It was the first spring of what the industry calls “the year of the AI agent explosion,” and a pivotal moment in the pharmaceutical industry's AI transformation.
Ms. Tian Ying, Co-founder & President of Weiming Penguin, was invited to deliver a keynote titled “The Pharmaceutical ‘Crayfish-Raising’ Expert—From Individuals to Enterprises: AI Agents Empowering Pharmaceutical Companies' Digital Upgrades.”



Personal “Crayfish-Raising” Is Booming, but Enterprise AI Must Follow the Rules


At the start of 2026, the OpenClaw “Little Crayfish” AI agent sparked a nationwide craze, with major players including Tencent, Alibaba, ByteDance, and Kimi joining in. Personal productivity soared, but so did risks such as runaway token usage, data leaks, and incorrect content.
President Tian Ying noted that pharmaceutical companies have two major fears about AI: falling behind, and, even more importantly, leaking confidential information. Core data, distribution data, and compliance information must never leave their controlled environment. Unmanaged AI may be worth trying out, but enterprise AI must operate under strict guardrails.
Weiming Penguin upholds three core principles:
- Absolute Security and Control:
Permission sandboxes, multilayer encryption, and data that stays within its controlled environment - Deep Alignment with Business Needs:
Address real pharmaceutical pain points, not “polished but empty talk” - Human Oversight as the Final Safeguard:
AI executes, people make decisions, and authority and accountability are clearly defined
AI Agents Are Already Deployed Across Pharmaceutical Workflows, Doubling Efficiency with Zero Data Risk



Truly AI-Native: Giving Agents a Head Start

President Tian Ying emphasized that being AI-native does not mean rebuilding from scratch; it means upgrading on the foundation of existing industry assets.

Weiming Penguin has pharmaceutical expertise in its DNA:
・Extensive built-in pharmaceutical knowledge bases, business SOPs, and compliance logic
・A closed loop across five technology modules: StarLink / Xingmai / StarFlow / StarCore / StarRealm
・Compared with the “unfinished shell” of general-purpose AI, a fully fitted pharmaceutical AI solution
As digital transformation in the pharmaceutical industry moves into deeper waters, Weiming Penguin has drawn on a decade of industry experience to launch StarPlex, its pharmaceutical AI agent platform. This is not a simple transplant of general-purpose AI, but an AI-native technology foundation purpose-built for the pharmaceutical and healthcare industry.
StarPlex deeply integrates four core technologies—knowledge graphs, dynamic ontology modeling, cross-domain relational reasoning, and multi-agent collaboration—to create an end-to-end intelligent closed loop spanning “data collection → intelligent governance → decision support → business execution.”
StarPlex: Four Core Capability Modules
🔹 StarLink — Intelligent Multimodal Data Collection Module
Multimodal data collection through DDI, APIs, FTP, email, intelligent image recognition, and more - 99% AI automation, with system integration completed in as little as 5 minutes
Experience directly connecting 13,000+ distributors/chains, with seamless compatibility across a thousand database types
🔹 StarFlow — Real-Time Data Governance Module
- Governance of a million distribution data records in 15 minutes, with an error rate of ≤0.3%
AI cognitive understanding + multidimensional intelligent decision support, with a 99% automated cleansing rate Embedded compliance rules to intercept risks before they occur
🔹 StarCore — Unified Semantics Development Module
1.82 million HCOs, 4.1 million HCPs, and 5 million scientific resources Ontology modeling to establish a unified data language for the pharmaceutical industry Dynamic semantic updates that adapt to business changes
🔹 StarRealm — Cross-Domain Relational Reasoning Module
Knowledge graph path reasoning and multidomain data integration Time-series forecasting and reinforcement learning–based decision support Risk early-warning engine and intelligent strategy generation



The Three “2” Commitments: Making Digital Transformation Tangible and Timely


To address the industry's pain points of “long lead times and black-box development,” Weiming Penguin officially introduced its 2+2+2 model
We are not here to be a tool vendor. We aim to be a partner that delivers value.
Looking ahead, Weiming Penguin will continue working with Saibailan and partners across the industry, using secure, compliant, deployable AI-native solutions to reshape the pharmaceutical industry's digital hub and usher in a new AI era together.




